Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Dr. David Reddy
Saving two lives, not just one: medicines for malaria during pregnancy

An estimated 125 million pregnancies around the world are at risk from malaria annually. For both mother and baby, the disease is potentially life-threatening and babies that do survive are often born with low birth weight, which is associated with negative impact on development.

Recent

David Jacobs
Research Roundup: Virus mapping, Zika complications, and antibiotic development

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Architect of the Capitol
Research Roundup: HIV drug resistance, the 21st Century Cures Act, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Aaron Joel Santos
Research Roundup: A Zika treatment, an HIV cure, and a MERS vaccine

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
A cornucopia of thanks

In the spirit of the Thanksgiving holiday, GHTC asked our members and staff to share what they are most thankful for in global health.

Read More
National Institute of Allergy and Infectious Diseases
Research Roundup: Long-lasting pills, HIV testing, and starving bacteria of iron

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gena Morgan
Why GHTC is joining the call for an essential diagnostics list

An essential diagnostic list list in a smart, cost-effective idea that could advance diagnostic R&D and access.

Read More
National Institute of Allergy and Infectious Diseases
Research Roundup: Treating drug-resistant infections, Ebola virus mutations, and Zika vaccine clinical trials

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Katrina Peach
TB epidemic looms large in era of declining R&D funding

October 2016 delivered two sobering wake-up calls: The tuberculosis (TB) epidemic is larger than many realized, and TB R&D has has fallen to its lowest level in seven years.

Read More
National Institute of Allergy and Infectious Diseases
Research Roundup: Cow antibodies, Zika’s impact on male fertility, and hepatitis C research

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Rob Oxley/DFID
DFID lays out vision to tackle global challenges through investments in research

The United Kingdom’s Department for International Development released it’s first-ever research review, laying out a vision for how it will invest £390 million in research and technology per year over the next four years to tackle the world’s toughest challenges.

PATH
Read More
National Institute of Allergy and Infectious Diseases
Research Roundup: Gene editing, mosquito takeover, and decoys for drug resistance

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
David Jacobs
Research Roundup: Pharmaceutical waste and superbugs, resistance to insecticides, and vaccines for crises

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Army Medicine
Research Roundup: Ebola treatment, black widow virus, and Zika syndrome

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
National Institute of Allergy and Infectious Diseases
Research Roundup: Flu vaccines, HIV in kids, and a cross-continental R&D partnership

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
TB Alliance
Research Roundup: Kid-friendly TB treatment, drug manufacturing on-the-go, diarrheal disease, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
UN Photo/Joao Araujo Pinto
How did global health R&D fare at UNGA 71?

The 71st United Nations General Assembly (UNGA) concluded this week. Breakthroughs gives a synopsis of the key global health R&D issues discussed at the assembly and what actions were taken.

Read More
GHTC/Matthew Robinson
The world commits to the AMR fight

At the United Nations General Assembly, world leaders made an unprecedented collective commitment to fighting the growing problem of antimicrobial resistance. GHTC and Global Health Council analyze what that commitment entails, why it matters, and the importance of what happens next.

Global Health Council
Read More
CDC/James Gathany
Research Roundup: Clinical trial data, Mayaro virus, antimicrobial resistance, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Evelyn Hockstein/PATH
Research Roundup: Trojan horse antibody against Ebola, the breakthrough that led to Hepatitis C cures, and Zika infection in monkeys

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
UN Photo/Loey Felipe
UNGA 2016: The world wakes up to AMR

The midtown Manhattan mayhem begins with the opening of the 71st United Nations General Assembly. GHTC preview the global health policy issues that will be discussed at this year's assembly.

Read More